[go: up one dir, main page]

DD202561A5 - Verfahren zur Herstellung von Salzen von Naphthyridin- und Chinolin-verbindungen - Google Patents

Verfahren zur Herstellung von Salzen von Naphthyridin- und Chinolin-verbindungen Download PDF

Info

Publication number
DD202561A5
DD202561A5 DD24062982A DD24062982A DD202561A5 DD 202561 A5 DD202561 A5 DD 202561A5 DD 24062982 A DD24062982 A DD 24062982A DD 24062982 A DD24062982 A DD 24062982A DD 202561 A5 DD202561 A5 DD 202561A5
Authority
DD
German Democratic Republic
Prior art keywords
acid
compound
solution
salts
gluconate
Prior art date
Application number
DD24062982A
Other languages
German (de)
English (en)
Inventor
Thomas F Mich
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of DD202561A5 publication Critical patent/DD202561A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Saccharide Compounds (AREA)
DD24062982A 1981-06-11 1982-06-10 Verfahren zur Herstellung von Salzen von Naphthyridin- und Chinolin-verbindungen DD202561A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27260181A 1981-06-11 1981-06-11
US33418281A 1981-12-24 1981-12-24

Publications (1)

Publication Number Publication Date
DD202561A5 true DD202561A5 (de) 1983-09-21

Family

ID=26955624

Family Applications (1)

Application Number Title Priority Date Filing Date
DD24062982A DD202561A5 (de) 1981-06-11 1982-06-10 Verfahren zur Herstellung von Salzen von Naphthyridin- und Chinolin-verbindungen

Country Status (17)

Country Link
EP (1) EP0067666B1 (fi)
KR (1) KR880002087B1 (fi)
AU (1) AU551596B2 (fi)
CA (1) CA1191842A (fi)
DD (1) DD202561A5 (fi)
DE (1) DE3267135D1 (fi)
DK (1) DK155998C (fi)
ES (1) ES8304117A1 (fi)
FI (1) FI78292C (fi)
GR (1) GR77194B (fi)
HU (1) HU188181B (fi)
IE (1) IE53259B1 (fi)
IL (1) IL66027A (fi)
NO (1) NO157739C (fi)
NZ (1) NZ200908A (fi)
PH (1) PH19091A (fi)
SU (1) SU1192624A3 (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3318145A1 (de) * 1983-05-18 1984-11-22 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-difluor-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
IT1196051B (it) * 1984-03-16 1988-11-10 Schiena Ricerche Composti ad attivita' antibatterica
DE3517709A1 (de) * 1985-01-05 1986-07-10 Bayer Ag Basische zubereitungen von chinoloncarbonsaeuren
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
HUT40429A (en) * 1985-04-29 1986-12-28 Chinoin Gyogyszer Es Vegyeszet Process for production of salts of derivatives of kynolin carbonic acid
DE3525335A1 (de) * 1985-07-16 1987-01-22 Bayer Ag Embonate von chinoloncarbonsaeuren und ihren derivaten
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
IT1196429B (it) * 1986-07-01 1988-11-16 Mediolanum Farmaceutici Srl Processo per la preparazione di pirido benzotiazine ad attivita' antibatterica e loro sali con acidi solfonici
IL80459A (en) * 1986-10-30 1991-04-15 Abic Ltd Water-soluble adduct of norfloxacin and nicotinic acid
US5188833A (en) * 1987-12-28 1993-02-23 Kyorin Seiyaku Kabushiki Kaisha Freeze-dried pharmaceutical preparations for parenteral use
JPH01175935A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 凍結乾燥注射剤
US4948894A (en) * 1989-02-21 1990-08-14 American Cyanamid Company 8-fluoro and 7, 8, 10-trifluoro-9-(substituted)-6-oxo-6H-benzo-(C)quinolizine-5-carboxylic acids
KR0159540B1 (ko) * 1992-01-21 1998-12-01 김정순 퀴놀론-카복실산의 염 및 그 함유조성물
ES2127036B1 (es) * 1994-03-21 1999-11-16 Ind Quimica Agropecuaria S A Aducto de norfloxacina soluble en agua.
ES2088742B1 (es) * 1994-06-29 1997-03-16 Salvat Lab Sa Composicion antibiotica de aplicacion otica.
DE19500784A1 (de) * 1995-01-13 1996-07-18 Bayer Ag Enrofloxacin-Injektions- oder Infusionslösungen
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
WO2008127060A1 (en) 2007-04-13 2008-10-23 Dong Wha Pharmaceutical Co. Ltd. Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza- spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
ZA811304B (en) * 1980-03-11 1982-06-30 Warner Lambert Co Pharmaceutical salts of 4'-(9-acridinylamino)methanesulfon-m-anisidide

Also Published As

Publication number Publication date
ES512969A0 (es) 1983-02-16
NO157739B (no) 1988-02-01
CA1191842A (en) 1985-08-13
FI78292B (fi) 1989-03-31
IE821390L (en) 1982-12-11
KR880002087B1 (ko) 1988-10-15
AU8475782A (en) 1982-12-16
DK155998C (da) 1989-11-06
SU1192624A3 (ru) 1985-11-15
DE3267135D1 (en) 1985-12-05
NO157739C (no) 1988-05-11
AU551596B2 (en) 1986-05-08
FI822066A0 (fi) 1982-06-10
FI78292C (fi) 1989-07-10
KR840000544A (ko) 1984-02-25
ES8304117A1 (es) 1983-02-16
IL66027A (en) 1986-02-28
DK155998B (da) 1989-06-12
EP0067666B1 (en) 1985-10-30
DK261582A (da) 1982-12-12
EP0067666A1 (en) 1982-12-22
IL66027A0 (en) 1982-09-30
GR77194B (fi) 1984-09-11
HU188181B (en) 1986-03-28
PH19091A (en) 1985-12-19
NO821931L (no) 1982-12-13
IE53259B1 (en) 1988-09-28
NZ200908A (en) 1984-09-28

Similar Documents

Publication Publication Date Title
DD202561A5 (de) Verfahren zur Herstellung von Salzen von Naphthyridin- und Chinolin-verbindungen
DE60026144T2 (de) Benzamidformulierung mit histon-deacetylase-inhibitoraktivität
DE69005992T2 (de) Psychotropische Wirkstoffe enthaltende stabilisierte Lösungen.
DE69014141T2 (de) Verwendung von Benzimidazol-Derivaten als antibakterielle Mittel.
DE2332878C2 (de) Salze von Cephalosporinen mit Arginin und Lysin, ihre Herstellung und injizierbare pharmazeutische Zubereitungen
DE60025627T2 (de) Pharmazeutische lösung von levosimendan
DE3031710A1 (de) Salze von (+)-catechin, deren herstellung und verwendung sowie diese salze enthaltende pharmazeutische zubereitungen.
EP2865391B1 (de) Verfahren zur Herstellung einer gefriergetrockneten pharmazeutischen Zusammensetzung mit Gehalt an Mitomycin C
EP0806955B1 (de) Enrofloxacin-injektions- oder infusionslösungen
DE3000743A1 (de) Arzneipraeparat auf der basis eines salzes der acetylsalicylsaeure und einer basischen aminosaeure und verfahren zu seiner herstellung
DE69808793T2 (de) Pharmazeutische zusammensetzungen aus dalfopristine und quinupristine und verfahren zu ihrer herstellung
DE2460929C2 (fi)
CH647677A5 (de) 4'-(acridinylamino)-methansulfon-anisidid enthaltende pharmazeutische zusammensetzung.
DE69115102T2 (de) Stabilisator für eine 4-ethyl-2-hydroxyimino-5-nitro-3-hexenamide enthaltende Zusammensetzung und Stabilisierungsverfahren.
DE1965343A1 (de) Arzneimittel,insbesondere zur Herabsetzung der Schleimviskositaet und Anwendung als hustenstillendes Mittel,und Verfahren zu seiner Herstellung
DE69231098T2 (de) Lyophilisierte zusammensetzung, die s(+)-4,4'-(1-methyl-1,2-ethandiyl)-bis(2,6-piperazindion)enthält
DE2655130C3 (de) Eine praktisch lösungsmittelfreie Kristallform des Cefacetril-Natriumsalzes
DE2236876B2 (de) N-Substituierte Aminocarbonsäuren und diese Verbindungen enthaltende Arzneimittel
DE2461570C3 (de) Arzneimittel für die Behandlung bakterieller Infektionen der Augen und/oder der Ohren und Verfahren zu ihrer Herstellung
EP0061654B1 (de) Vincamin-cyclamat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
DE1620177B2 (de) N-(2-Hydroxyäthyl) -piperazinocarboxymethyl-te tr acy elin, dessen pharmakologisch verwendbaren Salze, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE69322081T2 (de) Salze von chinolon carbonsäuren
DE3203274A1 (de) Vitamin k(pfeil abwaerts)3(pfeil abwaerts)-(gamma)-cyclodextrin-einschlusskomplex, verfahren zu dessen herstellung und diesen einschlusskomplex enthaltende praeparate
CH648023A5 (de) 4'-(9-acridinylamino)methansulfon-m-anisidid-gluconat und dieses enthaltende mischungen.
AT381024B (de) Verfahren zur herstellung eines pharmazeutischen mittels zur rekonstitution mit wasser